MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-02-0037038
Elisar Life Sciences Private Limited - healthcare in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.78 Cr
▼ 7% YoY
Net loss · FY 2025
₹4.38 Cr
Net margin -115.9%
EBITDA · FY 2025
-₹81 Lakh
EBITDA margin -21.4%
Authorised capital
₹9.5 Cr
Registered with MCA
Paid-up capital
₹8.38 Cr
Issued & subscribed
Company age
8 yrs
Est. 2018
Employees · EPFO
18
Provident fund records
Directors on board
2
As per MCA filings
About Elisar Life Sciences Private Limited
Data last updated:
Elisar Life Sciences Private Limited is a private limited company based in Chennai, Tamil Nadu, India, a subsidiary of Dr. Agarwal's Health Care Limited. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 26 November 2018 and has been in existence for over 8 years.
Its director Ashvin Agarwal is #1,750 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U33100TN2018PTC125932. Its GSTIN is 33AAFCE2718K1ZQ (Tamil Nadu).
The company has an authorised share capital of ₹9.5 Cr and a paid-up capital of ₹8.38 Cr. It is led by directors Anosh Agarwal and Ashvin Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1st Floor Buhari Towers No.4 Moores Road, Chennai, Tamil Nadu, India – 600006.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.78 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net loss of ₹4.38 Cr (net margin -115.9%) and EBITDA of -₹81 Lakh (EBITDA margin -21.4%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 28% over five years.
The company has about 18 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Elisar. The company has 1 deal on record (1 funding round), with disclosed funding of ₹2.28 Cr; the latest was in November 2019.
Elisar Life Sciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0037038). For more details, the company can be reached via its website elisar.com.
Company details
CIN U33100TN2018PTC125932
Registration Number 125932
Incorporation Date 26 November 2018
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Dr. Agarwal's Health Care Limited
MSME Classification Micro
Udyam Registration UDYAM-TN-02-0037038
Key People
Anosh Agarwal Director Ashvin Agarwal Director Recognitions & Rankings of Elisar Life Sciences
India's Richest People 2026 edition · 1 director · Source: Hurun India
- #1,750 Ashvin Agarwal ₹1,000 Cr
Contact details
Elisar Life Sciences Private Limited's registered office is in Chennai, Tamil Nadu. Its website is elisar.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1st Floor Buhari Towers No.4 Moores Road, Chennai, Tamil Nadu, India – 600006
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Elisar Life Sciences Private Limited, buy the company report.
Comprehensive company report
Elisar Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Elisar Life Sciences operates one associated brand: Elisar. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Creates advanced ophthalmic analyzers for precise eye diagnostics and assessments. | elisar.com |
Business activity
The main business activity of Elisar Life Sciences is manufacturing. In detail, this covers other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities |
To see the full business activity and turnover split of Elisar Life Sciences Private Limited, buy the company report.
Financials of Elisar Life Sciences Private Limited
FY 2025 filings availableElisar Life Sciences Private Limited reported revenue of ₹3.78 Cr (down 7% YoY) for FY 2025.
Revenue · FY 2025
₹3.78 Cr ▼ 7%
Net loss · FY 2025
₹4.38 Cr margin -115.9%
EBITDA · FY 2025
-₹81 Lakh margin -21.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 7%
3 years · compounded
▲ 6%
5 years · compounded
▲ 28%
EBITDA CAGR growth
1 year
▼ 179%
3 years · compounded
▲ 13%
5 years · compounded
▲ 21%
Revenue fell 7% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 28%. EBITDA fell 179% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹81 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.38 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -21.4% | ||||
| Net Profit Margin | -115.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Elisar Life Sciences Private Limited, buy the company report.
Board of directors of Elisar Life Sciences Private Limited
Elisar Life Sciences has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anosh Agarwal Also directs: Dr. Agarwal's Health Care Limited, Aditya Jyot Eye Hospital Private Limited, Idearx Services Private Limited and 1 more | Director | 26 Nov 2018 | 7 Years 10 Months | Current |
| Ashvin Agarwal | Director | 26 Nov 2018 | 7 Years 10 Months | Current |
Auditor
Elisar Life Sciences Private Limited is audited by M.K.Dandeker & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M.K.Dandeker & Co | FY 2023 | 000679S/S000103 |
Shareholding
The shareholding of Elisar Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Elisar Life Sciences Private Limited, buy the company report.
Deals & funding
Elisar Life Sciences Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹2.28 Cr; the latest was in November 2019.
Total deals
1
Funding round
1
Disclosed funding
₹2.28 Cr
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2019 | Funding round | ₹2.28 Cr | Investors: Dr. Agarwal's Health Care Limited , Dr. Agarwal’s Eye Institute |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Elisar Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Elisar Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Elisar Life Sciences Private Limited has a workforce of 18 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
18
Active EPFO establishments
1
GST
Elisar Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAFCE2718K1ZQ | Tamil Nadu | Active | 13 Dec 2018 |
To see the full GST registrations and return filing status of Elisar Life Sciences Private Limited, buy the company report.
Recent activity
Elisar Life Sciences Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Anosh Agarwal was appointed as Director on 26 Nov 2018.
AGM
Elisar Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Elisar Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Appointed
Anosh Agarwal was appointed as Director.
Appointed
Ashvin Agarwal was appointed as Director.
Incorporation
26 Nov 2018
Elisar Life Sciences Private Limited was registered on 26 Nov 2018 with Roc Chennai & aged 7 years 10 months as per MCA records.
Frequently asked questions
Elisar Life Sciences is an active private limited company based in Chennai, Tamil Nadu, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 26 November 2018 (8+ years old) and is registered under CIN U33100TN2018PTC125932.
Elisar Life Sciences has 2 current directors:
- Anosh Agarwal - Director
- Ashvin Agarwal - Director
The latest financial statements of Elisar Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Elisar Life Sciences is 33AAFCE2718K1ZQ, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Elisar Life Sciences is U33100TN2018PTC125932. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elisar Life Sciences was incorporated on 26 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chennai.
Elisar Life Sciences has 1 deal on record (1 funding round), with disclosed funding of ₹2.28 Cr; the latest was in November 2019.
Anosh Agarwal was appointed as Director on 26 Nov 2018. Ashvin Agarwal was appointed as Director on 26 Nov 2018.
Yes, Elisar Life Sciences is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0037038).
Elisar Life Sciences can be reached through the website elisar.com. Its registered office is in Chennai, Tamil Nadu, India.